BSBR Santander BR reports sharp Q1 2023 EPS miss edges modestly higher as investors look past nearterm weakness AbbVie Inc ABBV Former Senior Immunology RD Leader Anthony Slavin Appointed SVP of Portfolio Strategy at Infinimmune OPTU Optimum falls 958 as Q4 2025 earnings per share drastically underperform analyst expectations What availability Investar ISTR Q1 2026 Profit Surprises SherwinWilliams SHW PreEarnings Preview Q1 2026 Results Expectations and Key Investor Risks